World Equity Group, Inc. Zoetis Inc. Transaction History

World Equity Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jul 22, 2024	BUY	$151.44 - $200.09 $114,942 - $151,868	759 Added 41.84%	2,573 $508 Million
Q3 2023 Jul 22, 2024	BUY	$167.14 - $192.77 $303,191 - $349,684	1,814 New	1,814 $316 Million
Q2 2023 Aug 26, 2024	BUY	$160.94 - $186.23 $388,670 - $449,745	2,415 New	2,415 $416 Million
Q4 2022 Sep 06, 2024	SELL	$131.14 - $157.47 $32,522 - $39,052	-248 Reduced 8.42%	2,696 $395 Million
Q3 2022 Sep 06, 2024	BUY	$148.29 - $182.55 $436,565 - $537,427	2,944 New	2,944 $437 Million
Q2 2022 Sep 06, 2024	SELL	$155.97 - $200.09 $413,008 - $529,838	-2,648 Reduced 45.73%	3,142 $540 Million
Q1 2022 Sep 06, 2024	BUY	$181.39 - $234.03 $1.05 Million - $1.36 Million	5,790 New	5,790 $1.09 Billion

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.